T cell receptor beta variable 19 (TRBV19)

T cell receptor beta variable 19 (TRBV19) encodes the variable region segment of the beta chain in alpha-beta T cell receptors, which are essential cell surface proteins found on T lymphocytes that recognize specific antigens presented by the major histocompatibility complex (MHC) on antigen-presenting cells. The TRBV19 gene segment recombines with other gene segments during T cell development to produce the immense diversity found in T cell receptor repertoires. TRBV19 is a component of the antigen-binding domain of the T cell receptor but is not a discrete protein, enzyme, or pharmacological receptor by itself, and there are no approved drugs targeting this specific gene segment[1][2][3][5][7]. Its role is critical for immune defense, but it is not typically considered a standalone therapeutic target. Alterations or clonal usage of certain TRBV segments, including TRBV19, can be implicated in immune conditions, but the molecule itself is not a primary target for currently approved therapies.

Other names

TCRBV17S1A1TTCRBV19S1V_segment translation productTRBV19